InBody Co.,Ltd (KOSDAQ:041830)

Market Cap	336.51B
Revenue (ttm)	217.55B
Net Income (ttm)	30.62B
Shares Out	12.19M
EPS (ttm)	2,409.58
PE Ratio	11.45
Forward PE	9.70
Dividend	400.00 (1.40%)
Ex-Dividend Date	Mar 28, 2025

Volume	14,848
Average Volume	142,704
Open	27,600
Previous Close	27,600
Day's Range	27,600 - 28,400
52-Week Range	20,700 - 32,650
Beta	0.42
RSI	46.06
Earnings Date	Nov 11, 2025

About InBody Co.,Ltd

InBody Co.,Ltd provides body composition analysis solutions worldwide. It offers body composition analyzers, automatic blood pressure monitors, stadiometers, and body water analyzers, as well as InBody dial and bands. The company was formerly known as Biospace Co., Ltd. InBody Co.,Ltd was founded in 1996 and is headquartered in Seoul, South Korea.

• Industry: Medical - Specialties
• Sector: Healthcare
• Founded: 1996
• Employees: 342
• Stock Exchange: KOSDAQ
• Ticker Symbol: 041830

Financial Performance

In 2024, InBody Co.,Ltd's revenue was 204.46 billion, an increase of 20.03% compared to the previous year's 170.35 billion. Earnings were 33.14 billion, a decrease of -9.75%.